Michael Amoroso's Insider Trades & SAST Disclosures
Michael Amoroso's most recent trade in Abeona Therapeutics Inc was a trade of 36,101 Common Stock done . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Amoroso.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 180,466 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 115,388 | 143,925 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 69,421 | 138,842 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 37,079 | 74,138 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 20 Jan 2025 | 36,838 | 107,087 (0%) | 0% | 4.7 | 172,033 | Common Stock |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 8,888 | 8,888 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 9,443 | 9,444 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 9,443 | 31,549 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.19 per share. | 02 Nov 2024 | 3,012 | 28,537 (0%) | 0% | 8.2 | 24,668 | Common Stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 11,797 | 144,365 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2024 | 208,263 | 208,263 | - | - | Restricted Stock Units | |
| Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 23,611 | 132,568 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 12.00 per share. | 08 May 2024 | 8,334 | 22,106 (0%) | 0% | 12 | 100,008 | Common Stock |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,417 | 3,417 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,417 | 15,298 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.32 per share. | 01 May 2024 | 1,526 | 13,772 (0%) | 0% | 10.3 | 15,748 | Common Stock |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 111,217 | 111,217 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Amoroso Michael | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 266,720 | 493,823 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 266,720 | 533,280 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 20 Jan 2024 | 137,390 | 356,433 (0%) | 0% | 0.4 | 49,460 | Common Stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 20 Jun 2023 | 338 | 114,792 (0%) | 0% | 4.4 | 1,504 | Common Stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 4.62 per share. | 14 Jun 2023 | 58,689 | 115,130 (0%) | 0% | 4.6 | 271,143 | Common Stock |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 102,535 | 115,737 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 102,535 | 205,009 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 21 Mar 2023 | 46,999 | 68,738 (0%) | 0% | 0.8 | 38,539 | Common Stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 20 Mar 2023 | 268 | 56,441 (0%) | 0% | 2.3 | 624 | Common Stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 03 Mar 2023 | 1,002 | 56,709 (0%) | 0% | 2.4 | 2,385 | Common Stock |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 800,000 | 800,000 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 850,000 | 850,000 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 24,208 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 24,208 | 24,208 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 15 Oct 2022 | 11,006 | 13,202 (0%) | 0% | 1.3 | 14,528 | Common Stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 57,711 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 482,771 | 482,771 | - | - | Employee Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 307,544 | 307,544 | - | - | Restricted Stock Units | |
| Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 30 Sep 2021 | 45,409 | 604,637 (0%) | 0% | 1.1 | 49,382 | Common stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.87 per share. | 31 Mar 2021 | 45,409 | 650,046 (0%) | 0% | 1.9 | 84,919 | Common stock |
| Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Michael Amoroso | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 250,000 | 695,455 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 200,000 | 445,455 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 250,000 | 0 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Michael Amoroso | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges